1. Home
  2. LIVN

as 12-24-2024 1:39pm EST

$
-
-
.
-
-
-
$
-
.
-
-
-
-
.
-
-
%

Stocks

Health Care

Biotechnology: Electromedical & Electrotherapeutic Apparatus

Nasdaq

UK-based LivaNova was born of a combination between Cyberonics in the us and Sorin in Italy. The medical-device firm is primarily focused on cardiopulmonary solutions (with heart-lung machines and oxygenation equipment) as well as neuromodulation devices for treatment-resistant epilepsy and depression. Following the merger, LivaNova divested its cardiac rhythm management and heart valve businesses. It derives roughly half of its revenue from the us market, another 21% from Europe, and the remainder from the rest of the world.

Founded: 1987 Country:
United Kingdom
United Kingdom
Employees: N/A City: LONDON
Market Cap: 2.8B IPO Year: 1993
Target Price: $67.14 AVG Volume (30 days): 564.5K
Analyst Decision: Buy Number of Analysts: 7
Dividend Yield:
N/A
Dividend Payout Frequency: N/A
EPS: 0.43 EPS Growth: 759.09
52 Week Low/High: $43.15 - $64.48 Next Earning Date: 02-19-2025
Revenue: $1,241,739,000 Revenue Growth: 11.04%
Revenue Growth (this year): 10.1% Revenue Growth (next year): 5.43%

LIVN Daily Stock ML Predictions

Share on Social Networks: